I

Century Therapeutics
D

IPSC

1.63000
USD
0.28
(20.30%)
Market Closed
Volume
30,976
EPS
-2
Div Yield
-
P/E
-1
Market Cap
138,597,338
News

Title: Century Therapeutics

Sector: Healthcare
Industry: Biotechnology
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.